Guipi Pills in Treating Anemia of Patients Receiving Hemodialysis and the Influence on the Inflammatory Factors

OBJECTIVE To study on the influence of Guipi pills on anemia and the inflammatory factors of patients receiving hemodialysis. METHODS 60 patients diagnosed with CKD(stage 5)， CKD anemia and spleen deficiency and blood deficiency and have maintenance hemodialysis(MHD) were randomly divided into two groups with 30 cases in each group. The control group was treated with erythropoietin(EPO) and the treatment group， besides receiving EPO， took Guipi pills as well. The treatment lasted for 60 days. The hs-CRP， IL-6 and Hb were recorded before and after the treatment. RESULTS After the treatment， hs-CRP， IL-6 and Hb of both groups had significant decrease(P<0.05~0.01) and the treatment group was better than the control group(P<0.05~0.01). After the treatment， Hb of both groups increased(P<0.05~0.01) and still the treatment group was better than the control group(P<0.05). CONCLUSION Guipi pills are effective in treating anemia and inflammation of patients receiving hemodialysis.